Welcome to LookChem.com Sign In|Join Free

CAS

  • or

5725-79-1

Post Buying Request

5725-79-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

5725-79-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 5725-79-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,7,2 and 5 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 5725-79:
(6*5)+(5*7)+(4*2)+(3*5)+(2*7)+(1*9)=111
111 % 10 = 1
So 5725-79-1 is a valid CAS Registry Number.

5725-79-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-amino-4-hydroxychromen-2-one

1.2 Other means of identification

Product number -
Other names 3-Amino-4-hydroxy-cumarin

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:5725-79-1 SDS

5725-79-1Relevant articles and documents

Targeting adenosine receptors with coumarins: Synthesis and binding activities of amide and carbamate derivatives

Matos, Maria Jo?o,Gaspar, Alexandra,Kachler, Sonja,Klotz, Karl-Norbert,Borges, Fernanda,Santana, Lourdes,Uriarte, Eugenio

, p. 30 - 34 (2013)

Objectives With the aim of finding the structural features governing binding activity and selectivity against adenosine receptors (ARs), several 3-subtituted coumarins with amide (compounds 3-6) and carbamate (7-9) functions were synthesized. To study its possible influence on the binding activity and selectivity, a hydroxyl substituent was also introduced at position 4 of the coumarin moiety. Methods A new series of coumarins (3-9) were synthesized and evaluated by radioligand binding studies towards ARs. Key findings None of the 4-hydroxy derivatives (4, 8 and 9) showed binding affinity for any of the ARs. None of the compounds interacted with the hA2B AR (Ki > 100 000 nm). Compounds 3, 5, 6 and 7 had different activity profiles with dissimilar binding affinity and selectivity towards human A1, A 2A and A3 ARs. Conclusions The most remarkable derivative is compound 7, which presents the best affinity and selectivity for the A 3 adenosine receptor (Ki = 5500 nm).

A convergent paired electrochemical synthesis of new heterocyclic compounds. Reaction of benzoquinones with 3-Amino-4-hydroxycoumarin

Nematollahi,Karbasi

, p. 48 - 58 (2011)

Electrochemical oxidation of catechols (1) has been studied in the presence of cathodically generated 3-amino-4- hydroxycoumarin (3a) as a nucleophile in aqueous solutions, using cyclic voltammetry and controlled-potential coulometry. The results indicate that the o-benzoquinones derived from catechols (1) participate in Michael addition reaction with 3-amino-4- hydroxycoumarin (3a) to form the corresponding new heterocyclic compounds (7) (oxidized form of coumestan derivatives). The electrochemical process consists of a multi-step including (a) cathodic reduction of 4-hydroxy-3-nitrocoumarin (3) to 3-amino-4- hydroxycoumarin (3a), (b) anodic oxidation of catechols (1) to related o-benzoquinone (2), (c) the Michael addition reaction of 3- amino-4-hydroxycoumarin (3a) to o-benzoquinone (2), and (d) anodic oxidation of formed adduct. The paired electrochemical synthesis of compounds 7a and 7b has been successfully performed in a one-pot process at carbon rods as working and counter electrodes in an undivided cell.

Highly selective light-up Al3+ sensing by a coumarin based Schiff base probe: Subsequent phosphate sensing DNA binding and live cell imaging

Sheet, Sanjoy Kumar,Sen, Bhaskar,Thounaojam, Romita,Aguan, Kripamoy,Khatua, Snehadrinarayan

, p. 101 - 111 (2016/08/30)

A coumarin based simple fluorescent “turn-on” probe, 4-Hydroxy-3-[(2-hydroxy-5-methoxybenzylidene)-amino]-chromen-2-one (HMC), to detect metal ion based on the chelation enhanced fluorescence (CHEF), was synthesized by condensing 3-amino-4-hydroxycoumarin and 2-hydroxy-5-methoxybenzaldehyde. It was found to be highly selective and sensitive sensor for Al3+ in 90% aqueous methanol (MeOH: 0.01?M HEPES Buffer; 9:1; v/v) at pH 7.4 in fluorescence spectroscopy. Fluorescence intensity enhancement along with 10?nm blue shift was observed only in the presence of Al3+. The HMC binds Al3+ in 1:1 stoichiometry with a binding constant, Ka?=?(9.9?±?0.04)?×?103?M?1 and the detection limit was calculated to be as low as 1.62?μM. The binding mode of interaction with Al3+ and the chelate complex formation was supported with the help of a 1H NMR spectroscopy titration, ESI–MS and also by theoretical studies. Moreover, the HMC·Al3+ ensemble subsequently detected the biologically important phosphate ions and nucleotides via fluorescence quenching. The live cell imaging study indicated that HMC is highly efficient in the detection of exogenous Al3+ in living cell.

New Coumarin Derivatives as Anti-Breast and Anti-Cervical Cancer Agents Targeting VEGFR-2 and p38α MAPK

Batran, Rasha Z.,Dawood, Dina H.,El-Seginy, Samia A.,Ali, Mamdouh M.,Maher, Timothy J.,Gugnani, Kuljeet S.,Rondon-Ortiz, Alejandro N.

, (2017/09/05)

Breast and cervical cancers are the most common gender-specific cancers affecting women worldwide. In this investigation, we highlighted the synthesis, VEGFR-2 and p38α MAPK inhibitory activity of new series of fluorinated coumarin-based derivatives featuring a variety of bioactive chemical moieties attached or fused to the coumarin nucleus at the 3 and/or 4 position. The bioactive inhibitors were further assessed for their anti-proliferative effect against human MCF-7 breast cancer and HeLa cervical cancer cell lines, respectively. Most of the tested compounds showed potent preferential inhibition effects against human VEGFR-2 and remarkable anticancer activities in the human breast cancer cell line MCF-7. Compounds 29, 24, and 2 displayed the highest inhibitory activity against VEGFR-2 (94% inhibition) and they were the most potent anticancer agents toward MCF-7 cancer cells with IC50 values of 7.90, 8.28, and 8.30 μg/mL, respectively. Compound 13 inhibited p38α MAPK phosphorylation with a significant reduction in % cell viability against HeLa cancer cells at 10 and 30 μM. Docking experiments carried out on VEGFR-2 and p38 MAPK crystallographic structures revealed that the active compounds bind to the active sites through H-bonds, arene–cation, and hydrophobic π–π interactions. QSAR analysis demonstrated considerable correlation coefficient (R2 = 0.76969) and root mean square error (RMSE = 0.10446) values. Also, the residual values between the experimental pIC50 and predicted pIC50 are very close, indicating the reliability of the established QSAR model.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 5725-79-1